HIV drug resistance

HIV drug resistance

Antiretroviral drug resistance AIDS The resistance of a strain of HIV to an agent–eg, a reverse transcriptase inhibitor, which occurs in 5%-20% of those newly infected with HIV
References in periodicals archive ?
Additionally, the DHHS guidelines recommend darunavir-based regimens for those who may have suboptimal adherence and face the risk of developing HIV drug resistance, which is when a medication stops working to fight the virus.
700,000 annual deaths, 230,000 deaths from drug resistant TB in 2017, 214,000 neonatal sepsis deaths, 34,000 deaths from HIV drug resistance in SSA, AND morbidity data, viz.
WHO will host over 20 satellites, workshops or other events and will release several new publications, including on the use of dolutegravir in HIV treatment, HIV testing, preexposure prophylaxis, HIV drug resistance, toxicity monitoring, key populations and HIV strategic information.
WHO will host over 20 satellites, workshops or other events and will release several new publications, including on the use of dolutegravir in HIV treatment, HIV testing, pre-exposure prophylaxis, HIV drug resistance, toxicity monitoring, key populations and HIV strategic information.
The following data on treatment-experienced children and adolescents (<20 years of age at the time of application) who initiated a DRV/r-, RAL- or ETR-containing ART regimen prior to October 2016 were entered by one of the authors (VP) into a study database: demographic and HIV disease characteristics, previous ARV exposure, spectrum of HIV drug resistance mutations, ARV treatment regimens approved by the ERC, and early treatment outcomes.
(2011) showed low levels of HIV drug resistance in therapy naive pediatric patients (4.9%), but high levels in patients failing first-line cART (90%).
To identify an effective drug regimen and thereby prevent the further development and spread of HIV drug resistance, resistance must be identified before ART is initiated.
HIV drug resistance. Global report on early warning indicators of HIV drug resistance; 2016.
Four children had suspected HIV drug resistance but confirmed in 2 (6.7%) requiring second-line therapy.
We categorized information on epidemiology, key populations, treatment and care, antiretroviral therapy (ART) access, prevention of mother-to-child transmission of HIV, community viral suppression, and HIV drug resistance. We examined each peer-reviewed publication for the research evidence to assess its validity, study design, results, applicability, accuracy of reporting, and relevance prior to inclusion in the descriptive review.
WHO is therefore launching a report on "Early Warning Indicators of HIV drug resistance" in Durban this week to help countries monitor factors that may contribute to the problem.